| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66453893 |
| PharmacoGx | BRD-K66453893 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RANBP3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | FBXO5 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | UBE2Z | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | CPSF3L | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | CELA3B | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | FAM124A | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | MAP3K11 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | YWHAG | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | STOML2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | TGOLN2 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
